 CAMBRIDGE, Mass., Feb. 17, 2022 GLOBE NEWSWIRE -- Relay Therapeutics, Inc. Nasdaq: RLAY, a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, plans to report fourth quarter and full year 2021 financial results and corporate highlights after the close of market on Thursday, February 24, 2022. The company will not be conducting a teleconference in conjunction with its financial results press release. 